Tissue Regenix warns it could go bust this month without emergency funding
York-based regenerative medical devices firm Tissue Regenix is facing a race against time to secure emergency capital to prevent it going bust in the coming weeks.
The company revealed it has ‘very limited cash balances’ and a ‘substantial backlog of creditors’, leaving the business unable to continue trading beyond the end of November without fresh funding.The AIM-listed company- whose shares remain temporarily suspended following last month’s shock... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
